Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Medical Services Advisory Committee. Ocriplasmin for symptomatic vitreomacular adhesion (sVMA) including macular hole. Canberra: Medical Services Advisory Committee (MSAC). MSAC application 1370. 2014 Authors' conclusions Optical coherence tomography (OCT) is part of standard clinical practice for diagnosing a wide range of macular and retinal diseases. It is proposed that OCT be used as a procedure in patients with sVMA including those associated with full thickness macular hole (FTMH) for the purpose of identifying eligibility for treatment with ocriplasmin (on the Pharmaceutical Benefits Scheme); and for assessment of treatment outcome. Indexing Status Subject indexing assigned by NLM MeSH Adult; Double-Blind Method; Eye Diseases /drug therapy; Fibrinolysin /therapeutic uses; Intravitreal Injections; Peptide Fragments /therapeutic use; Retina /pathology; Retinal Perforations /drug therapy; Visual Acuity; Vitreous Body /pathology Language Published English Country of organisation Australia English summary An English language summary is available. Address for correspondence MDP 106, GPO Box 9848, Canberra ACT 2601 AUSTRALIA Email: msac.secretariat@health.gov.au AccessionNumber 32015000574 Date abstract record published 27/05/2015 |